Skip NavigationSkip to Content

Longitudinal changes in CD4(+) T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients

  1. Author:
    Gea-Banacloche, J. C.
    Martino, L.
    Mican, J. M.
    Hallahan, C. W.
    Baseler, M.
    Stevens, R.
    Lambert, L.
    Polis, M.
    Lane, H. C.
    Connors, M.
  2. Author Address

    NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA. NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA. SAIC Frederick Canc Res & Dev Ctr, Frederick, MD USA.
    1. Year: 2000
  1. Journal: Aids Research and Human Retroviruses
    1. 16
    2. 17
    3. Pages: 1877-1886
  2. Type of Article: Article
  1. Abstract:

    Although skewing of the CD4(+) TCR repertoire in advanced HIV infection is well documented, increases in polyclonality during antiretroviral therapy have been less consistently observed. Ten patients, each with documented abnormalities within the CD4(+) TCR repertoire, were studied by CDR3 spectratyping, semiquantitative PCR, and SSCP during 9-26 months of therapy. Naive and memory cell phenotypes were analyzed by flow cytometry. Six of 10 patients showed increased polyclonality of their TCR repertoires, 1 showed no change, and 3 showed increased TCR skewing, despite suppressed viral replication. Overall, there was no significant change in the percentage of abnormal BV subfamilies (from a mean of 25.5 to 17.1%) or the percentage of naive CD4(+) T cells (from a mean of 18 to 25%). Further, progression of TCR repertoire disruptions was observed in some patients even with suppression of plasma viral RNA below 500 copies/ml. Although a spectrum of changes may be seen within the CD4(+) TCR repertoire in the setting of antiretroviral therapy, increases in polyclonality are observed in some patients.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel